Markéta Hušáková

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

Sofía Ramiro, Elena Nikiphorou, Alexandre Sepriano et al. · Annals of the Rheumatic Diseases · 2022 · 808 citations · Full text

Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis

Andrea Levitová, Hana Hulejová, Maja Špiritović et al. · Arthritis Research & Therapy · 2016 · 61 citations · Full text

Association between circulating miRNAs and spinal involvement in patients with axial spondyloarthritis

Klára Prajzlerová, Kristýna Grobelná, Markéta Hušáková et al. · PLoS ONE · 2017 · 35 citations · Full text

Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis

Markéta Hušáková, Anne‐Christine Bay‐Jensen, Šárka Forejtová et al. · Scientific Reports · 2019 · 23 citations · Full text

Immunology, Pathology, Type Ii +16

Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study

Jakub Závada, Michal Uher, R. Svobodová et al. · Arthritis Research & Therapy · 2015 · 22 citations · Full text

Active Sle, Autoimmune Disease, Disease Progression +11